2021

• Bos A.V., Erkelens M.N., Koenders S.T.A., Stelt M. van der, Egmond M. van & Mebius R.E. (2021), Clickable Vitamins as a New Tool to Track Vitamin A and Retinoic Acid in Immune Cells, Frontiers in Immunology 12: 671283. article in journal: refereed
• Jones P.S., Boucharens S., McElroy S.P., Morrison A., Honarnejad S., Boeckel S. van, Hurk H. van den, Basting D., Hüser J., Jaroch S., Ottow E., Benningshof J., Folmer R.H.A., Leemhuis F., Kramer-Verhulst P.M., Nies V.J.M., Orrling K.M., Rijnders T., Pfander C., Engkvist O., Pairaudeau G., Simpson P.B., Ortholand J.Y., Roche D., Dömling A., Kühnert S.M., Roevens P.W.M., Vlijmen H. van, Wanrooij E.J.A. van, Verbruggen C., Nussbaumer P., Ovaa H., Stelt M. van der, Simonsen K.B., Tagmose L., Waldmann H., Duffy J., Finsinger D., Jurzak M., Burgess-Brown N.A., Lee W.H., Rutjes F.P.J.T., Haag H., Kallus C., Mors H., Dorval T., Lesur B., Ramon Olayo F., Hamza D., Jones G., Pearce C., Piechot A., Tzalis D., Clausen M.H., Davis J., Derouane D., Vermeiren C., Kaiser M., Stockman R.A., Barrault D.V., Swedlow J.R., Nelson A.S., Orru R.V.A., Ruijter E., Helden S.P. van, Li V.M., Vries T. & Vlieger J.S.B. de (2021), IMI European Lead Factory - democratizing access to high-throughput screening, Nature Reviews Drug Discovery 20(2): 85-90. article in journal: refereed
• Prokop S., Ábrányi-Balogh P., Barti B., Vámosi M., Zöldi M., Barna L., Urbán G.M., Tóth A.D., Dudok B., Egyed A., Deng H., Leggio G.M., Hunyady L., Stelt M. van der, Keserű G.M. & Katona I. (2021), PharmacoSTORM nanoscale pharmacology reveals cariprazine binding on Islands of Calleja granule cells, Nature Communications 12: 6505. article in journal: refereed
• Alexander S.P., Fabbro D., Kelly E., Mathie A., Peters J.A., Veale E.L., Armstrong J.F., Faccenda E., Harding S.D., Pawson A.J., Southan C., Davies J.A., Boison D., Burns K.E., Dessauer C., Gertsch J., Helsby N.A., Izzo A.A., Koesling D., Ostrom R., Pyne N.J., Pyne S., Russwurm M., Seifert R., Stasch J.P., Stelt M. van der, Vliet A. van der, Watts V. & Wong S.S. (2021), The concise guide to pharmacology 2021/2: enzymes, British Journal of Pharmacology 178(S1): S313-S411. article in journal: refereed
• Duca M., Gillingham D., Olsen C.A., Sbardella G., Skaanderup P.R., Stelt M. van der, Vauzeilles B., Vázquez O. & Auberson Y.P. (2021), The chemical biology-medicinal chemistry continuum: EFMC's vision, ChemBioChem 22(19): 2823-2825. article in journal: refereed
• Eenige R. van Ying Z. Tambyrajah L. Pronk A.C.M. Blomberg N. Giera M Wang Y. Coskun T. Stelt M. van der Rensen P.C.N. Kooijman S. (2021), Cannabinoid type 1 receptor inverse agonism attenuates dyslipidemia and atherosclerosis in APOE∗3-Leiden.CETP mice, Journal of Lipid Research 62: 100070. article in journal: refereed
• Chatterjee S.D. Zhou J. Dasgupta R. Cramer-Blok A.J. Timmer M. Stelt M. van der Ubbink M. (2021), Protein dynamics influence the enzymatic activity of phospholipase a/acyltransferases 3 and 4, Biochemistry 60(15): 1178-1190. article in journal: refereed
• Mock E.D., Kotsogianni I., Driever W.P.F., Fonseca C.S., Vooijs J.M., Dulk H. den, Boeckel C.A.A. van & Stelt M. van der (2021), Structure–activity relationship studies of pyrimidine-4-carboxamides as inhibitors of N-acylphosphatidylethanolamine phospholipase D, Journal of Medicinal Chemistry 64(1): 481-515. article in journal: refereed
• Sarott R.C., Westphal M.V., Pfaff P., Korn C., Sykes D.A., Gazzi T., Brennecke B., Atz K., Weise M., Mostinski Y., Hompluem P., Koers E., Miljuš T., Roth N.J., Asmelash H., Vong M.C., Piovesan J., Guba W., Rufer A.C., Kusznir E.A., Huber S., Raposo C., Zirwes E.A., Osterwald A., Pavlovic A., Moes S., Beck J., Benito-Cuesta I., Grande T., Ruiz de Martin Esteban S., Yeliseev A., Drawnel F., Widmer G., Holzer D., Wel T. van der, Mandhair H., Yuan C.Y., Drobyski W.R., Saroz Y., Grimsey N., Honer M., Fingerle J., Gawrisch K., Romero J., Hillard C.J., Varga Z.V., Stelt M. van der, Pacher P., Gertsch J., McCormick P.J., Ullmer C., Oddi S., Maccarrone M., Veprintsev D.B., Nazaré M., Grether U. & Carreira E.M. (2020), Development of high-specificity fluorescent probes to enable cannabinoid type 2 receptor studies in living cells, Journal of the American Chemical Society 142(40): 16953-16964. article in journal: refereed
• Egmond N. van, Straub V.M. & Stelt M. van der (2021), Targeting endocannabinoid signaling: FAAH and MAG lipase inhibitors, Annual Review of Pharmacology and Toxicology 61: 441-463. article in journal: refereed

2020

• Mock E.D., Kotsogianni I., Driever W.P.F., Fonseca C.S., Vooijs J.M., Dulk H. den, Boeckel C.A.A. van & Stelt M. van der (2020), Structure–activity relationship studies of pyrimidine-4-carboxamides as inhibitors of N-acylphosphatidylethanolamine phospholipase D, Journal of Medicinal Chemistry .article in journal: refereed
• Sarott R.C., Westphal M.V., Pfaff P., Korn C., Sykes D.A., Gazzi T., Brennecke B., Atz K., Weise M., Mostinski Y., Hompluem P., Koers E., Miljuš T., Roth N.J., Asmelash H., Vong M.C., Piovesan J., Guba W., Rufer A.C., Kusznir E.A., Huber S., Raposo C., Zirwes E.A., Osterwald A., Pavlovic A., Moes S., Beck J., Benito-Cuesta I., Grande T., Ruiz de Martin Esteban S., Yeliseev A., Drawnel F., Widmer G., Holzer D., Wel T van der., Mandhair H., Yuan C.Y., Drobyski W.R., Saroz Y., Grimsey N., Honer M., Fingerle J., Gawrisch K., Romero J., Hillard C.J., Varga Z.V., Stelt M. van der, Pacher P., Gertsch J., McCormick P.J., Ullmer C., Oddi S., Maccarrone M., Veprintsev D.B., Nazaré M., Grether U. & Carreira E.M. (2020), Development of High-Specificity Fluorescent Probes to Enable Cannabinoid Type 2 Receptor Studies in Living Cells, Journal of the American Chemical Society 142(40): 16953-16964.article in journal: refereed
• Zhou J., Mock E.D., Al Ayed K., Di X., Kantae V., Burggraaff L., Stevens A.F., Martella A., Mohr F., Jiang M., Wel T. van der, Wendel T.J., Ofman T.P., Tran Y., Koster N. de, Westen G.J.P. van, Hankemeier T. & Stelt M. van der (2020), Structure-Activity Relationship Studies of α-Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family., Journal of Medicinal Chemistry .article in journal: refereed
• Armstrong Z., Kuo C.L., Lahav D., Liu B., Johnson R., Beenakker T.J.M., Boer C. de, Wong C.S., Rijssel E.R. van, Debets M.F., Florea B.I., Hissink C., Boot R.G., Geurink P.P., Ovaa H., Stelt M. van der, Marel G.A. van der, Codée J.D.C., Aerts J.M.F.G., Wu L., Overkleeft H.S. & Davies G.J. (2020), Manno-epi-cyclophellitols Enable Activity-Based Protein Profiling of Human α-Mannosidases and Discovery of New Golgi Mannosidase II Inhibitors, Journal of the American Chemical Society .article in journal: refereed
• Wel T. van der, Hilhorst R, Dulk H. den, Hooven T. van den, Prins N.M., Wijnakker J.A.P.M., Florea B.I., Lenselink E.B., Westen G.J.P. van, Ruijtenbeek R., Overkleeft H.S., Kaptein A., Barf T. & Stelt M. van der (2020), Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis, Nature Communications 11(1): 3216.article in journal: refereed
• Mock E.D., Mustafa M., Gunduz-Cinar O., Cinar R., Petrie G.N., Kantae V., Di X., Ogasawara D., Varga Z.V., Paloczi J., Miliano C., Donvito G., Esbroeck A.C.M. van, Gracht A.M.F. van der, Kotsogianni I., Park J.K., Martella A., Wel T. van der, Soethoudt M., Jiang M., Wendel T.J., Janssen A.P.A., Bakker A.T., Donovan C.M., Castillo L.I., Florea B.I., Wat J., Hurk H. van den, Wittwer M., Grether U., Holmes A., Boeckel C.A.A. van, Hankemeier T., Cravatt B.F., Buczynski M.W., Hill M.N., Pacher P., Lichtman A.H. & Stelt M. van der (2020), Discovery of a NAPE-PLD inhibitor that modulates emotional behavior in mice, Nature Chemical Biology 16(6): 667-675.article in journal: refereed
• Voorneveld J., Florea B.I., Mendowicz R.J., Veer M.S. van der, Gagestein B., Stelt M. van der, Overkleeft H.S. & Filippov D.V. (2020), Olaparib based photo-affinity probes for PARP-1 detection in living cells, ChemBioChem .article in journal: refereed
• Koenders S.T.A., Rooden E.J. van, Elst H. van den, Florea B.I., Overkleeft H.S. & Stelt M. van der (2020), STA-55, An Easily Accessible Broadspectrum Activity-Based Aldehyde Dehydrogenase Probe, ChemBioChem .article in journal: refereed
• Zhang H., Lapointe B.T., Anthony N., Azevedo R., Cals J., Correll C.C., Daniels M., Deshmukh S., Eenenaam H. van, Ferguson H., Hegde L.G., Karstens W.J., Maclean J., Miller J.R., Moy L.Y., Simov V., Nagpal S., Oubrie A., Palte R.L., Parthasarathy G., Sciammetta N., Stelt M. van der, Woodhouse J.D., Trotter B.W. & Barr K. (2020), Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases, Acs Medicinal Chemistry Letters 11(2): 114-119.article in journal: refereed
• Yasmin F., Colangeli R., Morena M., Filipski S., Stelt M. van der, Pittman Q.J., Hillard C.J., Teskey G.C., McEwen B.S., Hill M.N. & Chattarji S. (2020), Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala, PNAS 117(1): 650-655.article in journal: refereed
• Gianessi C.A., Groman S.M., Thompson S.L., Jiang M., Stelt M. van der & Taylor J.R. (2020), Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment, Addiction Biology 25(3): e12768.article in journal: refereed

2019

• Esbroeck A.C.M. van, Kantae V., Di X., Wel T. van der, Dulk J.. den, Stevens A.F., Singh S., Bakker A.T., Florea B.I., Stella N., Overkleeft H.S., Hankemeier T. & Stelt M. van der (2019), Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells, Frontiers in Molecular Neuroscience 12: 286.article in journal: refereed
• Alexander S.P.H., Fabbro D., Kelly E., Mathie A., Peters J.A., Veale E.L., Armstrong J.F., Faccenda E., Harding S.D., Pawson A.J., Sharman J.L., Southan C. & Davies J.A. (2019), The Concise Guide to Pharmacology 2019/20: Enzymes, British Journal of Pharmacology 176: S297–S396.article in journal: refereed
• Koenders S.T.A., Wijaya L.S., Erkelens M.N., Bakker A.T., Noord V.E. van der, Rooden E.J. van, Burggraaff L., Putter P.C., Botter E., Wals K., Elst H. van den, Dulk H. den, Florea B.I., Water B. van de, Westen G.J.P. van, Mebius R.E., Overkleeft H.S., Le Dévédec S.E. & Stelt M. van der (2019), Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells, ACS Central Science 5(12): 1965-1974.article in journal: refereed
• Esbroeck A.C.M. van, Varga Z.V., Di X., Rooden E.J. van, Tóth V.E., Onódi Z., Kuśmierczyk M., Leszek P., Ferdinandy P., Hankemeier T., Stelt M. van der & Pacher P. (2019), Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system, Pharmacological Research 151: 104578.article in journal: refereed
• Esbroeck A.C.M. van, Kantae V., Di X., Wel T. van der, Dulk J. den, Stevens A.F., Singh S., Bakker A.T., Florea B.I., Stella N., Overkleeft H.S., Hankemeier T. & Stelt M. van der (2019), Identification of alpha,beta-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells, Frontiers in Molecular Neuroscience 12: 286.article in journal: refereed
• Baggelaar M.P., Dulk H. den, Florea B.I., Fazio D., Bernab Ograve N., Raspa M., Janssen A.P.A., Scavizzi F., Barboni B., Overkleeft H.S., Maccarrone M. & Stelt M. van der (2019), ABHD2 inhibitor identified by activity-based protein profiling reduces acrosome reaction, ACS Chemical Biology 14(10): 2295-2304.article in journal: refereed
• Janssen A.P.A., Hengst J.M.A. van, Béquignon O.J.M., Deng H., Westen G.J.P. van & Stelt M. van der (2019), Structure Kinetics Relationships and Molecular Dynamics Show Crucial Role for Heterocycle Leaving Group in Irreversible Diacylglycerol Lipase Inhibitors, Journal of Medicinal Chemistry 62(17): 7910-7922.article in journal: refereed
• Gianessi C.A., Groman S.M., Thompson S.L., Jiang M., Stelt M. van der & Taylor J.R. (2019), Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment, Addiction Biology : e12768.article in journal: refereed
• Esbroeck A.C.M. van, Kantae V., Di X., Wel T. van der, Dulk J. den, Stevens A.F., Singh S., Bakker A.T., Florea B.I., Stella N., Overkleeft H.S., Hankemeier T. & Stelt M. van der (2019), Identification of alpha,beta-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells, Frontiers in Molecular Neuroscience 12: 286.article in journal: refereed
• Janssen A.P.A., Grimm S.H., Wijdeven R.H.M., Lenselink E.B., Neefjes J., Boeckel C.A.A. van, Westen G.J.P. van & Stelt M. van der (2019), Drug Discovery Maps, a Machine Learning Model That Visualizes and Predicts Kinome–Inhibitor Interaction Landscapes, Journal of Chemical Information and Modeling 59(3): 1221-1229.article in journal: refereed
• Esbroeck A.C.M. van, Varga Z.V., Di X., Rooden E.J. van, Tóth V.E., Onódi Z., Kuśmierczyk M., Leszek P., Ferdinandy P., Hankemeier T., Stelt M. van der & Pacher P. (2019), Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system, Pharmacological Research 151: 104578.article in journal: refereed
• Baggelaar M.P., Dulk H. den, Florea B.I., Fazio D., Bernab Ograve N., Raspa M., Janssen A.P.A., Scavizzi F., Barboni B., Overkleeft H.S., Maccarrone M. & Stelt M. van der (2019), ABHD2 inhibitor identified by activity-based protein profiling reduces acrosome reaction, ACS Chemical Biology 14(10): 2295-2304.article in journal: refereed
• Janssen A.P.A., Hengst J.M.A. van, Béquignon O.J.M., Deng H., Westen G.J.P. van & Stelt M. van der (2019), Structure Kinetics Relationships and Molecular Dynamics Show Crucial Role for Heterocycle Leaving Group in Irreversible Diacylglycerol Lipase Inhibitors, Journal of Medicinal Chemistry 62(17): 7910-7922.article in journal: refereed
• Gianessi C.A., Groman S.M., Thompson S.L., Jiang M., Stelt M. van der & Taylor J.R. (2019), Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment, Addiction Biology : e12768.article in journal: refereed
• Grimm S.H., Gagestein B., Keijzer J.F., Liu N., Wijdeven R.H., Lenselink E.B., Tuin A.W., Nieuwendijk A.M.C.H. van den, Westen G.J.P. van, Boeckel C.A.A. van, Overkleeft H.S., Neefjes J. & Stelt M. van der (2019), Comprehensive structure-activity-relationship of azaindoles as highly potent FLT3 inhibitors, Bioorganic and Medicinal Chemistry 27(5): 692-699.article in journal: refereed
• Zhou J., Mock E.D., Martella A., Kantae V., Di X., Burggraaff L., Baggelaar M.P., Al-Ayed K., Bakker A., Florea B.I., Grimm S.H., Dulk H. den, Li C.T., Mulder L., Overkleeft H.S., Westen G.J.P. van, Hankemeier T. & Stelt M. van der (2019), Activity-based protein profiling identifies α-ketoamides as inhibitors for Phospholipase A2 Group XVI, ACS Chemical Biology 14(2): 164-169.article in journal: refereed
• Koenders S.T.A., Gagestein B. & Stelt M. van der (2019), Opportunities for Lipid-Based Probes in the Field of Immunology. In: Cravatt B., Hsu K.L., Weerapana E. (Eds.) Activity-Based Protein Profiling. Current Topics in Microbiology and Immunology no. 420 Berlin, Heidelberg: Springer,. 283-319.book chapter

2018

• Soethoudt M., Alachouzos G., Rooden E.J. van, Moya Garzón M.D., Berg R.J.B.H.N. van den, Heitman L.H. & Stelt M. van der (2018), Development of a Cannabinoid-Based Photoaffinity Probe to Determine the D8/9- Tetrahydrocannabinol Protein Interaction Landscape in Neuroblastoma Cells, Cannabis and Cannabinoid Research 3(1): 136-151.article in journal: refereed
• Kuipers E.N., Kantae V., Maarse B.C.E., Berg S.M. van den, Eenige R. van, Nahon K.J., Reifel-Miller A., Coskun T., Winther M.P.J. de, Lutgens E., Kooijman S., Harms A.C., Hankemeier T., Stelt M. van der, Rensen P.C.N. & Boon M.R. (2018), High Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue, Frontiers in Physiology 9: 1913.article in journal: refereed
• Weerdt I. de, Hofland T., Lameris R, Endstra S., Jongejan A., Moerland P.D., Bruin R.C.G. de, Remmerswaal E.B.M., Berge I.J.M. ten, Liu N., Stelt M. van der, Faber L.M., Levin M.D., Eldering E., Tonino S.H., Gruijl T.D. de, Vliet H.J. van der & Kater A.P. (2018), Improving CLL Vg9Vd2-T–cell fitness for cellular therapy by ex vivo activation and ibrutinib, Blood 132(21): 2260-2272.article in journal: refereed
• Saliba S.W., Jauch H., Gargouri B., Keil A., Hurrle T., Volz N., Mohr F., Stelt M. van der, Bräse S. & Fiebich B.L. (2018), Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells, Journal of Neuroinflammation .article in journal: refereed
• Jiang M. & Stelt M. van der (2018), Activity-Based Protein Profiling Delivers Selective Drug Candidate ABX-1431, a Monoacylglycerol Lipase Inhibitor, To Control Lipid Metabolism in Neurological Disorders, Journal of Medicinal Chemistry 61(20): 9059-9061.article in journal: refereed
• Stelt & M. van der (19 October 2018), Lichaamseigen marihuana: inspiratie voor geneesmiddelenonderzoek (Inaugural address. Leiden Institute of Chemistry (LIC), Wis- en Natuurwetenschappen, Universiteit Leiden).inaugural address
• Janssen A.P.A., Vliet D. van der, Bakker A.T., Jiang M., Grimm S.H., Campiani G., Butini S. & Stelt M. van der (2018), Development of a Multiplexed Activity-Based Protein Profiling Assay to Evaluate Activity of Endocannabinoid Hydrolase Inhibitors, ACS Chemical Biology 13(9): 2406-2413.article in journal: refereed
• Yang X., Michiels T.J.M., Jong C. de, Soethoudt M., Dekker N., Gordon E., Stelt M. van der, Heitman L.H., Es D. van der & IJzerman A.P. (2018), An Affinity-Based Probe for the Human Adenosine A(2A) Receptor, Journal of Medicinal Chemistry 61(17): 7892-7901.article in journal: refereed
• Baggelaar M.P., Maccarrone M. & Stelt M. van der (2018), 2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain, Progress in Lipid Research 71: 1-17.article in journal: refereed
• Nahon K.J., Kantae V., Haan R. den, Hanssen M.J.W., Harms A.C., Stelt M. van der, Hankemeier T., Jazet I.M., Marken Lichtenbelt W.D. van, Rensen P.C.N. & Boon M.R. (2018), Gene expression of endocannabinoid system components in skeletal muscle and adipose tissue of South Asians and White Caucasians with overweight, Obesity 26(8): 1332-1337.article in journal: refereed
• Rooden E.J. van, Kreekel R., Hansen T., Janssen A.P.A., Esbroeck A.C.M. van, Dulk H. den, Berg R.J.B.H.N. van den, Codee J.D.C. & Stelt M. van der (2018), Two-step activity-based protein profiling of diacylglycerol lipase, Organic and Biomolecular Chemistry 16: 5250-5253.article in journal: refereed
• Rooden E.J. van, Esbroeck A.C.M. van, Baggelaar M.P., Deng H., Florea, B.I., Rosa Alcalde Marques A., Ottenhoff R., Boot R.G., Overkleeft H.S., Aerts J.M.F.G. & Stelt M. van der (2018), Chemical Proteomic Analysis of Serine Hydrolase Activity in Niemann-Pick Type C Mouse Brain, Frontiers in Neuroscience 12: 440.article in journal: refereed
• Rooden E.J. van, Kohsiek M.J.J., Kreekel R., Esbroeck A.C.M. van, Nieuwendijk A.M.C.H. van den, Janssen A.P.A., Berg R.J.B.H.N. van den, Overkleeft H.S. & Stelt M. van der (2018), Design and Synthesis of Quenched Activity-based Probes for Diacylglycerol Lipase and alpha,beta-Hydrolase Domain Containing Protein 6, Chemistry - An Asian Journal 13(22): 3491-3500.article in journal: refereed
• Eenige R. van, Stelt M. van der, Rensen P.C.N. & Kooijman S. (2018), Regulation of Adipose Tissue Metabolism by the Endocannabinoid System, Trends in Endocrinology and Metabolism 29(5): 326-337.article in journal: refereed
• Rooden E.J. van, Florea B.I., Deng H., Baggelaar M.P., Esbroeck A.C.M. van, Zhou J., Overkleeft H.S. & Stelt M. van der (2018), Mapping in vivo target interaction profiles of covalent inhibitors using chemical proteomics with label-free quantification, Nature protocols 13(4): 752-767.article in journal: refereed
• Soethoudt M., Hoorens M.W.H., Doelman W., Martella A., Stelt M. van der & Heitman L.H. (2018), Structure-kinetic relationship studies of cannabinoid CB2 receptor agonists reveal substituent-specific lipophilic effects on residence time, Biochemical pharmacology 152: 129-142.article in journal: refereed
• Wilkerson J.L., Curry Z.A., Kinlow P.D., Mason B.L., Hsu K.L., Stelt M. van der, Cravatt B.F. & Lichtman A.H. (2018), Evaluation of different drug classes on transient sciatic nerve injury-depressed marble burying in mice, Pain 159(6): 1155-1165.article in journal: refereed
• Gutiérrez-Rodríguez A., Bonilla-Del Río I., Puente N., Gómez-Urquijo S.M., Fontaine C.J., Egaña-Huguet J., Elezgarai I., Ruehle S., Lutz B., Robin L.M., Soria-Gómez E., Bellocchio L., Padwal J.D., Stelt M. van der, Mendizabal-Zubiaga J., Ramos A., Reguero L., Marsicano G., Gerrikagoitia I. & Grandes P. (2018), Localization of the cannabinoid type-1 receptor in subcellular astrocyte compartments of mutant mouse hippocampus, Glia 66(7): 1417-1431.article in journal: refereed
• Soethoudt M., Stolze S.C., Westphal M.V., Stralen L. van, Martella A., Rooden E.J. van, Guba W., Varga Z.V., Deng H., Kasteren S.I. van, Grether U., IJzerman A.P., Pacher P., Carreira E.M., Overkleeft H.S., Heitman L.H., Ioan-Facsinay A. & Stelt M. van der (2018), A selective photoaffinity probe that enables assessment of cannabinoid CB2 receptor expression and ligand engagement in human cells, Journal of the American Chemical Society 140(19): 6067-6075.article in journal: refereed
• Rooden E.J. van, Bakker A.T., Overkleeft H.S. & Stelt M. van der (2018), Activity-based protein profiling. In: eLS.: John Wiley & Sons, Ltd.book chapter
• Eyk H.J. van, Schinkel L.D. van, Kantae V., Dronkers C.E.A., Westenberg J.J.M., Roos A. de, Lamb H.J., Jukema J.W., Harms A.C., Hankemeier T., Stelt M. van der, Jazet I.M., Rensen P.C.N. & Smit J.W.A. (2018), Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes, Nutrition and Diabetes 8(1): 6.article in journal: refereed
• Chiurchiù V., Stelt M. van der, Centonze D. & Maccarrone M. (2018), The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases., Progress in neurobiology 160: 82-100.article in journal: refereed
• Deng H. & Stelt M. van der (2018), Chemical tools to modulate 2‐arachidonoylglycerol biosynthesis, Biotechnology and Applied Biochemistry 65(1): 9-15.article in journal: refereed

2017

• Lahav D., Liu B., Berg, R.J.B.H.N. van den, Nieuwendijk A.M.C.H. van den, Wennekes T., Ghisaidoobe A.T., Breen I., Ferraz M.J., Kuo C.L., Wu L., Geurink P.P., Ovaa H., Marel G.A. van der, Stelt M. van der, Boot R.G., Davies G.J., Aerts J.M.F.G. & Overkleeft H.S. (2017), A Fluorescence Polarization Activity-Based Protein Profiling Assay in the Discovery of Potent, Selective Inhibitors for Human Nonlysosomal Glucosylceramidase, Journal of the American Chemical Society 138(40): 14192-14197.article in journal: refereed
• Petracca R., Romeo E., Baggelaar M.P., Artola M., Pontis S., Ponzano S., Overkleeft H.S., Stelt M. van der & Piomelli D. (2017), Novel activity-based probes for N-acylethanolamine acid amidase, Chemical Communications 53(86): 11810-11813.article in journal: refereed
• Martella A., Sijben H., Rufer A.C., Grether U., Fingerle J., Ullmer C., Hartung T., IJzerman A.P., Stelt M. van der & Heitman L.H. (2017), A Novel Selective Inverse Agonist of the CB2 Receptor as a Radiolabeled Tool Compound for Kinetic Binding Studies, Molecular Pharmacology 92(4): 389-400.article in journal: refereed
• Narhe B.D., Breman A.C., Padwal J., Vandenput D.A.L., Scheidt J.M., Benningshof J.C.J., Marel G.A. van der, Overkleeft H.S., Stelt M. van der & Filippov D.V. (2017), Piperidine and octahydropyrano[3,4-c] pyridine scaffolds for drug-like molecular libraries of the European Lead Factory, Bioorganic and Medicinal Chemistry 25(19): 5160-5170.article in journal: refereed
• Kantae V., Nahon K.J., Straat M.E., Bakker L.E.H., Harms A.C., Stelt M. van der, Hankemeier T., Jazet I.M., Boon M.R. & Rensen P.C.N. (2017), Endocannabinoid tone is higher in healthy lean South Asian than white Caucasian men, Scientific Reports 7(1): 7558.article in journal: refereed
• Esbroeck A.C.M. van, Janssen A.P.A., Cognetta A.B. III, Ogasawara D., Shpak G., Kroeg M. van der, Kantae V., Baggelaar M.P., Vrij F.M.S. de, Deng H., Allara M., Fezza F., Lin Z., Wel T. van der, Soethoudt M., Mock E.D., Dulk H. den, Baak I.L., Florea B.I., Hendriks G., Petrocellis L. de, Overkleeft H.S., Hankemeier T., Zeeuw C.I. de, Di Marzo V., Maccarrone M., Cravatt B.F., Kushner S.A. & Stelt M. van der (2017), Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474, SCIENCE 356(6342): 1084-1087.article in journal: refereed
• Deng H., Wel T. van der, Berg R.J.B.H.N. van den, Nieuwendijk A.M.C.H. van den, Janssen F.J., Baggelaar M.P., Overkleeft H.S. & Stelt M. van der (2017), Chiral disubstituted piperidinyl ureas: a class of dual diacylglycerol lipase-alpha and ABHD6 inhibitors, MEDCHEMCOMM 8(5): 982-988.article in journal: refereed
• Baggelaar M.P., Esbroeck A.C.M. van, Rooden E.J. van, Florea B.I., Overkleeft H.S., Marsicano G., Chaouloff F. & Stelt M. van der (2017), Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases, ACS CHEMICAL BIOLOGY 12(3): 852-861.article in journal: refereed
• Kantae V., Ogino S., Noga M.J., Harms A.C., Dongen R.M. van, Onderwater G.L.J., Maagdenberg A.M.J.M. van den, Terwindt G.M., Stelt M. van der, Ferrari M.D. & Hankemeier T. (2017), Quantitative profiling of endocannabinoids and related N-acylethanolamines in human CSF using nano LC-MS/MS, Journal of Lipid Research 2017(58): 615-624.article in journal: refereed
• Soethoudt M., Grether U., Fingerle J., Grim T.W., Fezza F., Petrocellis L. de, Ullmer C., Rothenhäusler B., Perret C., Gils N. van, Finlay D., MacDonald C., Chicca A., Gens M.D., Stuart J., Vries H. de, Mastrangelo N., Xia L., Alachouzos G., Baggelaar M.P., Martella A., Mock E.D., Deng H., Heitman L.H., Connor M., Di Marzo V., Gertsch J., Lichtman A.H., Maccarrone M., Pacher P., Glass M. & Stelt M. van der (2017), Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity, Nature Communications 8: 13958.article in journal: refereed
• Baggelaar M.P. & Stelt M. van der (2017), Competitive ABPP of Serine Hydrolases: A Case Study on DAGL-Alpha. In: Activity-Based Proteomics: Methods and Protocols.: Springer New York. 161-169.book chapter
• Deng H., Kooijman S., Nieuwendijk A.M.C.H. van den, Ogasawara D., Wel T. van der, Dalen F. van, Baggelaar M.P., Janssen F.J., Berg R.J.B.H.N. van der, Dulk J. den, Cravatt B.F., Overkleeft H.S., Rensen P.C. & Stelt M. van der (2017), Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding, Journal of medicinal chemistry 60(1): 428-440.article in journal: refereed

2016

• Zadelhoff G. van & Stelt M. van der (2016), Oxygenation of Anandamide by Lipoxygenases. In: Maccarrone M. (Ed.) Endocannabinoid Signaling: Methods and Protocols. Methods in molecular biology (Clifton, N.J.) no. 1412: Springer New York. 217-225.book chapter
• Soethoudt M., van Gils N., Stelt M. van der & Heitman L.H. (2016), Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors.. In: Maccarrone M. (Ed.) Endocannabinoid Signaling: Methods and Protocols. Methods in molecular biology (Clifton, N.J.) no. 1412: Springer New York. 103-111.book chapter
• Janssen F.J. & Stelt M. van der (2016), Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders, Bioorganic & medicinal chemistry letters : 3831-7.article in journal: refereed
• Xin B.T., Bruin G. de, Huber E.M., Besse A., Florea B.I., Filippov D.V., Marel G.A. van der, Kisselev A.F., Stelt M. van der, Driessen C., Groll M. & Overkleeft H.S. (2016), Structure-Based Design of β5c Selective Inhibitors of Human Constitutive Proteasomes, Journal of medicinal chemistry 59(15): 7177-7187.article in journal: refereed
• Stolze S.C., Liu N., Wijdeven R.H., Tuin A.W., Nieuwendijk A.M. van den, Florea B.I., Stelt M. van der, Marel G.A. van der, Neefjes J.J. & Overkleeft H.S. (2016), Photo-crosslinking of clinically relevant kinases using H89-derived photo-affinity probes, Molecular Biosystems 12(6): 1809-1817.article in journal: refereed
• Bruin G. de, Xin B.T., Kraus M., Stelt M. van der, Marel G.A. van der, Kisselev A.F., Driessen C., Florea B.I. & Overkleeft H.S. (2016), A Set of Activity-Based Probes to Visualize Human (Immuno)proteasome Activities, Angewandte Chemie International Edition 55(13): 4199-4203.article in journal: refereed
• Mukhopadhyay P., Baggelaar M., Erdelyi K., Cao Z., Cinar R., Fezza F., Ignatowska-Jankowska B., Wilkerson J., Gils N. van, Hansen T., Ruben M., Soethoudt M., Heitman L., Kunos G., Maccarrone M., Lichtman A., Pacher P. & Stelt M. van der (2016), The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity, British Journal of Pharmacology 173(3): 446–458.article in journal: refereed
• Ogasawara D., Deng H., Viader A., Baggelaar M.P., Breman A., Dulk H. den, Nieuwendijk A.M.C.H. van den, Soethoudt M., Wel T. van der, Zhou J., Overkleeft H.S., Sanchez-Alavez M., Mori S., Nguyen W., Conti B., Liu X., Chen Y., Liu Q., Cravatt B.F. & Stelt M. van der (2016), Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition, Proceedings of the National Academy of Sciences of the United States of America 113(1): 26-33.article in journal: refereed

2015

• Ouairy C.M.J., Ferraz M.J., Boot R.G., Baggelaar M.P., Stelt M. van der, Appelman M., Marel G.A. van der, Florea B.I., Aerts J.M.F.G. & Overkleeft H.S. (2015), Development of an acid ceramidase activity-based probe, Chemical Communications 51(28): 6161-6163.article in journal: refereed
• Liu N., Hoogendoorn S., Kar B. van de, Kaptein A., Barf T., Driessen C., Filippov D.V., Marel G.A. van der, Stelt M. van der & Overkleeft H.S. (2015), Direct and two-step bioorthogonal probes for Bruton's tyrosine kinase based on ibrutinib: a comparative study, ORGANIC & BIOMOLECULAR CHEMISTRY 13(18): 5147-5157.article in journal: refereed
• Scheepstra M., Leysen S., Almen G.C. van, Miller J.R., Piesvaux J., Kutilek V., Eenennaam H. van, Zhang H., Barr K., Nagpal S., Soisson S.M., Kornienko M., Wiley K., Elsen N., Sharma S., Correll C.C., Trotter B.W., Stelt M. van der, Oubrie A., Ottmann C., Parthasarathy G. & Brunsveld L. (2015), Identification of an allosteric binding site for RORγt inhibition., NATURE COMMUNICATIONS 6: 8833.article in journal: refereed
• Janssen F.J., Baggelaar M.P., Hummel J.J.A., Overkleeft H.S., Cravatt B.F., Boger D.L. & Stelt M. van der (2015), Comprehensive Analysis of Structure-Activity Relationships of alpha-Ketoheterocycles as sn-1-Diacylglycerol Lipase alpha Inhibitors, JOURNAL OF MEDICINAL CHEMISTRY 58(24): 9742-9753.article in journal: refereed
• Baggelaar M.P., Chameau P.J.P., Kantae V., Hummel J., Hsu K.L., Janssen F., Wel T. van der, Soethoudt M., Deng H., den Dulk H., Allara M., Florea B.I., Di Marzo V., Wadman W.J., Kruse C.G., Overkleeft H.S., Hankemeier T., Werkman T.R., Cravatt B.F. & Stelt M. van der (2015), Highly Selective, Reversible Inhibitor Identified by Comparative Chemoproteomics Modulates Diacylglycerol Lipase Activity in Neurons, Journal of the American Chemical Society 137(27): 8851-8857.article in journal: refereed
• Padwal J.D., Filippov D.V., Narhe B.D., Aertssen S., Beuving R.J., Benningshof J.C.J., Marel G.A. van der, Overkleeft H.S. & van der Stelt M. (2015), Cyclopentitol as a scaffold for a natural product-like compound library for drug discovery, Bioorganic and Medicinal Chemistry 23(11): 2650-2655.article in journal: refereed
• T. van der Wel, Janssen F.J., Baggelaar M.P., Deng H., Dulk H. den, Overkleeft H.S. & Stelt M. van der (2015), A natural substrate-based fluorescence assay for inhibitor screening on diacylglycerol lipase alpha, Journal of Lipid Research 56(4): 927-935.article in journal: refereed

2014

• Ghisaidoobe Amar T., van den Berg Richard J. B. H. N., Butt Saleem S., Strijland Anneke, Donker-Koopman Wilma E., Scheij Saskia, van den Nieuwendijk Adrianus M. C. H., Koomen Gerrit-Jan, van Loevezijn Arnold, Leemhuis Mark, Wennekes Tom, van der Stelt Mario, van der Marel Gijsbert A., van Boeckel Constant A. A., Aerts Johannes M. F. G. & Overkleeft Herman S. (2014), Identification and Development of Biphenyl Substituted Iminosugars as Improved Dual Glucosylceramide Synthase/Neutral Glucosylceramidase Inhibitors, JOURNAL OF MEDICINAL CHEMISTRY 57(21): 9096-9104.article in journal: refereed
• Janssen F.J., Deng H., Baggelaar M.P., Allara M., Wel T. van der, Dulk J. den, Ligresti A., Esbroeck A.C.M. van, McGuire R., Marzo V. Di, Overkleeft H.S. & Stelt M. van der (2014), Discovery of Glycine Sulfonamides as Dual Inhibitors of sn-1-Diacylglycerol Lipase alpha and alpha/beta-Hydrolase Domain 6, Journal of medicinal chemistry 57(15): 6610-6622.article in journal: refereed
• Willems Marian M. J. H. P., Zom Gijs G., Khan Selina, Meeuwenoord Nico, Melief Cornelis J. M., van der Stelt Mario, Overkleeft Herman S., Codee Jeroen D. C., van der Marel Gijsbert A., Ossendorp Ferry & Filippov Dmitri V. (2014), N-Tetradecylcarbamyl Lipopeptides as Novel Agonists for Toll-like Receptor 2, JOURNAL OF MEDICINAL CHEMISTRY 57(15): 6873-6878.article in journal: refereed
• de Bruin Gerjan, Huber Eva M., Xin Bo-Tao, van Rooden Eva J., Al-Ayed Karol, Kim Kyung-Bo, Kisselev Alexei F., Driessen Christoph, van der Stelt Mario, van der Marel Gijsbert A., Groll Michael & Overkleeft Herman S. (2014), Structure-Based Design of beta 1i or beta 5i Specific Inhibitors of Human Immunoproteasomes, JOURNAL OF MEDICINAL CHEMISTRY 57(14): 6197-6209.article in journal: refereed

2013

• Baggelaar M.P., Janssen F.J., Esbroeck A.C.M. van, Dulk J. den, Allara M., Hoogendoorn S., McGuire R., Florea B.I., Meeuwenoord N.J, Elst H. van den, Marel G.A. van der, Brouwer J., Marzo V. Di, Overkleeft H.S. & Stelt M. van der (2013), Development of an Activity-Based Probe and In Silico Design Reveal Highly Selective Inhibitors for Diacylglycerol Lipase-alpha in Brain, Angewandte Chemie International Edition 52(46): 12081-12085.article in journal: refereed
• Geurink Paul P., van der Linden Wouter A., Mirabella Anne C., Gallastegui Nerea, de Bruin Gerjan, Blom Annet E. M., Voges Mathias J., Mock Elliot D., Florea Bogdan I., van der Marel Gijs A., Driessen Christoph, van der Stelt Mario, Groll Michael, Overkleeft Herman S. & Kisselev Alexei F. (2013), Incorporation of Non-natural Amino Acids Improves Cell Permeability and Potency of Specific Inhibitors of Proteasome Trypsin-like Sites, JOURNAL OF MEDICINAL CHEMISTRY 56(3): 1262-1275.article in journal: refereed

2011

• Stelt M. van der, Cals J., Broeders-Josten S., Cottney J., Doelen A.A. van der, Hermkens M., Kimpe V. de, King A., Klomp J., Oosterom J., Pols-de Rooij I., Roos J., Tilborg M. van, Boyce S. & Baker J. (2011), Discovery and Optimization of 1-(4-(Pyridin-2-yl)benzyl)imidazolidine-2,4-dione Derivatives As a Novel Class of Selective Cannabinoid CB2 Receptor Agonists, JOURNAL OF MEDICINAL CHEMISTRY 54(20): 7350-7362.article in journal: refereed
• Verkaar F., Stelt M. van der, Blankesteijn W.M., Doelen A.A. van der & Zaman G.J.R. (2011), Discovery of Novel Small Molecule Activators of beta-Catenin Signaling, PLoS ONE 6(4): e19185.article in journal: refereed

2008

• Thiemann G., Stelt M. van der, Petrosino S., Molleman A., Di Marzo V. & Hasenoehrl R.U. (2008), The role of the CB1 cannabinoid receptor and its endogenous ligands, anandamide and 2-arachidonoylglycerol, in amphetamine-induced behavioural sensitization, Behavioural Brain Research 187(2): 289-296.article in journal: refereed

2007

• Marinelli S., Di Marzo V., Florenzano F., Fezza F., Viscomi M.T., Stelt M. van der, Bernardi G., Molinari M., Maccarrone Mauro & Mercuri N.B. (2007), N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors, Neuropsychopharmacology 32(2): 298-308.article in journal: refereed

2006

• Cascio M.G., Bisogno T., Palazzo E., Thomas A., Stelt M. van der, Brizzi A., De Novellis V., Marabese I., Ross R., Doelen T. van de, Brizzi V., Pertwee R., Maione S. & Di Marzo V. (2006), In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands, British Journal of Pharmacology 149(4): 431-440.article in journal: refereed
• Wettschureck N., Stelt M. van der, Tsubokawa H., Krestel H., Moers A., Petrosino S., Schütz G., Di Marzo V. & Offermanns S. (2006), Forebrain-specific inactivation of Gq/G11 family G proteins results in age-dependent epilepsy and impaired endocannabinoid formation, Molecular and Cellular Biology 26(15): 5888-5894.article in journal: refereed
• Stelt M. van der, Mazzola C., Esposito G., Matias I., Petrosino S., De Filippis D., Micale V., Steardo .L, Drago F., Iuvone T. & Di Marzo V. (2006), Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels, Cellular and Molecular Life Sciences 63(12): 1410-1424.article in journal: refereed

2005

• Stelt M. van der & Marzo V. Di (2005), Cannabinoid receptors and their role in neuroprotection, NeuroMolecular Medicine 7(1-2): 37-50.article in journal: refereed
• Stelt M. van der & Marzo V. Di (2005), Anandamide as an intracellular messenger regulating ion channel activity, Prostaglandins and Other Lipid Mediators 77(1-4): 111-122.article in journal: refereed
• Stelt M. van der, Trevisani M., Vellani V., Petrocellis L. De, Moriello A.S., Campi B., McNaughton P., Geppetti P. & Marzo V. Di (2005), Anandamide acts as an intracellular messenger amplifying Ca2+ influx via TRPV1 channels, The EMBO journal 24(17): 3026-3037.article in journal: refereed
• Stelt M. van der, Fox S.H., Hill M., Crossman A.R., Petrosino S., Marzo V. Di & Brotchie J.M. (2005), A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTPlesioned non-human primate models of Parkinson's disease, FASEB JOURNAL 19(7): 1140.article in journal: refereed

2004

• Stelt M. van der & Marzo V. Di (2004), Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels, European Journal of Biochemistry 271(10): 1827-1834.article in journal: refereed
• Ligresti A., Morera E., Stelt M. van der, Monory K., Lutz B., Ortar G. & Di Marzo V. (2004), Further evidence for the existence of a specific process for the membrane transport of anandamide, Biochemical Journal 380(1): 265-272.article in journal: refereed

2003

• Stelt M. van der, Hansen H.H., Veldhuis W.B., Bär P.R., Nicolay K., Veldink G.A., Vliegenthart J.F. & Hansen H.S. (2003), Biosynthesis of endocannabinoids and their modes of action in neurodegenerative diseases, Neurotoxicity Research 5(3): 183-200.article in journal: refereed
• Stelt M. van der & Di Marzo V. (2003), The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders, European Journal of Pharmacology 480(1-3): 133-150.article in journal: refereed
• Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S..C, Cascio M.G., Gutierrez S.O., Stelt M. van der, Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C. & Lutz B. (2003), CB1 cannabinoid receptors and on-demand defense against excitotoxicity, SCIENCE 302(5642): 84-88.article in journal: refereed
• Stelt M. van der, Veldhuis W.B., Wadman M.W., Zadelhoff G. van, Fezza F., Veldink G.A., Vliegenthart J.F.G., Bar P.R., Nicolay K. & Di Marzo V. (2003), Mechanisms underlying in vivo neuroprotection by the endocannabinoid anandamide and the cannabinoid/vanilloid receptor agonist, arvanil, Journal of Neurochemistry 85(s2): 6-6.article in journal: refereed
• Veldhuis W.B., Stelt M. van der, Wadman M.W., Zadelhoff G. van, Maccarrone M., Fezza F., Veldink G.A., Vliegenthart J.F.G., Bar P.R., Nicolay K. & Di Marzo V. (2003), Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: Role of vanilloid receptors and lipoxygenases, Journal of Neuroscience 23(10): 4127-4133.article in journal: refereed
• Veldhuis W.B., Stelt M. van der, Delmas F., Gillet B., Veldink G.A., Vliegenthart J.F.G., Nicolay K. & Bar P.R. (2003), In vivo excitotoxicity induced by ouabain, a Na+/K+-ATPase inhibitor, Journal of Cerebral Bloodflow and Metabolism 23(1): 62-74.article in journal: refereed

2002

• Stelt M. van der, Kuik J.A. van, Bari M., Zadelhoff G. van, Leeflang B.R., Veldink G.A., Finazzi-Agro A., Vliegenthart J.F.G. & Maccarrone M. (2002), Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: Conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase, Journal of Medicinal Chemistry 45(17): 3709-3720.article in journal: refereed

2001

• Stelt M. van der, Veldhuis W.B., Haaften G.W. van, Fezza F., Bisogno T., Bar P..R, Veldink G.A., Vliegenthart J.F.G., Di Marzo V. & Nicolay K. (2001), Exogenous anandamide protects rat brain against acute neuronal injury in vivo, Journal of Neuroscience 21(22): 8765-8771.article in journal: refereed
• Stelt M. van der, Veldhuis W..B, Bar P.R., Veldink G..A, Vliegenthart J.F.G. & Nicolay K. (2001), Neuroprotection by Delta(9)-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity, Journal of Neuroscience 21(17): 6475-6479.article in journal: refereed

2000

• Stelt M. van der, Noordermeer M.A., Kiss T., Zadelhoff G. van, Merghart B., Veldink G.A. & Vliegenthart J.F.G. (2000), Formation of a new class of oxylipins from N-acyl(ethanol)amines by the lipoxygenase pathway, European Journal of Biochemistry 267(7): 2000-2007.article in journal: refereed

1998

• Maccarrone M., Stelt M. van der, Rossi A., Veldink G.A., Vliegenthart J.F.G. & Agrio A.F. (1998), Anandamide hydrolysis by human cells in culture and brain, Journal of Biological Chemistry 273(48): 32332-32339.article in journal: refereed

1997

• Stelt M. van der, Nieuwenhuizen W.F., Veldink G.A., & Vliegenthart J.F.G. (1997), Dioxygenation of N-linoleoyl amides by soybean lipoxygenase-1, FEBS LETTERS 411(2-3): 287-290.article in journal: refereed
• Stelt, M. van der, Paoletti A.M., Maccarrone M., Nieuwenhuizen W.F., Bagetta G., Veldink G.A., Finazzi Agrò A. & Vliegenthart J.F.G. (1997), The effect of hydroxylation of linoleoyl amides on their cannabinomimetic properties, FEBS LETTERS 415(3): 313-316.article in journal: refereed